M.G. Chambers
Impact in
- Rheumatology top 0.2%
- Osteoarthritis Treatment and Mechanisms
Papers in
- Rheumatology 27
- Osteoarthritis Treatment and Mechanisms 27
- Pharmacology 10
- Inflammatory mediators and NSAID effects 5
- Cannabis and Cannabinoid Research 4
- Co-authors
- Christopher B. Little (1 shared paper)S.S. Glasson (1 shared paper)Wim B. van den Berg (1 shared paper)Roger M. Mason (9 shared papers)Michael T. Bayliss (3 shared papers)J.L. Oskins (14 shared papers)Chaohua Lin (14 shared papers)Kristen M. Clements (1 shared paper)
- Journals
- Osteoarthritis and Cartilage (16 papers)Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)ACS Medicinal Chemistry Letters (2 papers)JCI Insight (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
M.G. Chambers
48 papers receiving 3k citations
M.G. Chambers's Hit Papers
Peers
Comparison fields: 5 of 81
- Rheumatology 2.1k
- Complementary and Manual Therapy 27
- Neurology 181
- Pharmacology 164
- Cancer Research 107
Countries citing papers authored by M.G. Chambers
This map shows the geographic impact of M.G. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G. Chambers more than expected).
Fields of papers citing papers by M.G. Chambers
This network shows the impact of papers produced by M.G. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G. Chambers. The network helps show where M.G. Chambers may publish in the future.
Co-authors
The 25 scholars most cited alongside M.G. Chambers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouse Hit paper breakdown → | 2010 | 1400 |
| 2 | 2003 | 189 | |
| 3 | 2012 | 141 | |
| 4 | 2001 | 116 | |
| 5 | 2013 | 113 | |
| 6 | 2014 | 108 | |
| 7 | 2001 | 99 | |
| 8 | 2003 | 76 | |
| 9 | 2002 | 68 | |
| 10 | 2010 | 67 | |
| 11 | 2010 | 65 | |
| 12 | 2016 | 60 | |
| 13 | 2002 | 47 | |
| 14 | 2006 | 45 | |
| 15 | 2012 | 43 | |
| 16 | 2013 | 43 | |
| 17 | 2016 | 42 | |
| 18 | 2006 | 28 | |
| 19 | 2003 | 27 | |
| 20 | 2002 | 25 |
About M.G. Chambers
M.G. Chambers is a scholar working on Rheumatology, Pharmacology, Computational Theory and Mathematics, Cancer Research and Physiology, having authored 48 papers that have together received 3.1k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (27 papers), Computational Drug Discovery Methods (7 papers), Protease and Inhibitor Mechanisms (5 papers), Inflammatory mediators and NSAID effects (5 papers), Cannabis and Cannabinoid Research (4 papers), Pain Mechanisms and Treatments (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Sphingolipid Metabolism and Signaling (2 papers). The work is most often cited by research in Rheumatology (2.1k citations), Complementary and Manual Therapy (27 citations), Neurology (181 citations), Pharmacology (164 citations) and Cancer Research (107 citations). M.G. Chambers has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Christopher B. Little, S.S. Glasson, Wim B. van den Berg, Roger M. Mason, Michael T. Bayliss, J.L. Oskins, Chaohua Lin, Kristen M. Clements, A. Robin Poole and Denise M. Visco. Their work appears in journals such as Osteoarthritis and Cartilage, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.